Publication - Abstract
Apr 03, 2020
International Journal of Pharmaceutics
C. Webb, N. Forbes, C.B. Roces, G. Anderluzzi, G. Lou, S. Abraham, L. Ingalls, K. Marshall, T.J. Leaver, J.A. Watts, J.W. Aylott, and Y. Perrie
In a 2020 study conducted by researchers at the University of Strathclyde Institute of Pharmacy and Biomedical Sciences, a scale-by-scale development of genetic medicines from bench to GMP was outlined through the generation of liposomes with a protein payload using two different...
Read More
Publication - Abstract
Oct 10, 2018
Drug Delivery and Translational Research
M. Sedighi, S. Sieber, F. Rahimi, M.A. Shahbazi, A.H. Rezayan, J. Huwyler and D. Witzigmann
Liposomes have attracted much attention as the first nanoformulations entering the clinic. The optimization of physicochemical properties of liposomes during nanomedicine development however is time-consuming and challenging despite great advances in formulation development. Here...
Read More